Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,139Revenue (TTM) $M199Net Margin (%)-52.0Altman Z-Score1.2
Enterprise Value $M1,099EPS (TTM) $-3.1Operating Margin %-47.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score3.8Pre-tax Margin (%)-52.4Higher ROA y-yY
Price/Book35.210-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsN
Price/Sales6.55-y EBITDA Growth Rate %--Current Ratio3.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-47.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CHRSJoel Greenblatt 2016-09-30 Buy 0.01%$16.43 - $31.57
($27.28)
$ 26.10-4%New holding17,363
CHRSGeorge Soros 2016-03-31 Sold Out -0.05%$12.54 - $22.96
($16.44)
$ 26.1059%Sold Out0
CHRSGeorge Soros 2015-06-30 Buy 0.04%$21.07 - $30.58
($25.36)
$ 26.103%New holding127,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CHRS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herman Alan C.Chief Scientific Officer 2017-01-03Sell11,333$27.95-6.62view
Viret Jean-FredericCFO 2016-12-16Sell3,900$28.3-7.77view
Wahlstrom MatsDirector 2016-12-08Sell53,583$27.52-5.16view
Herman Alan C.Chief Scientific Officer 2016-12-01Sell11,333$27.4-4.74view
Viret Jean-FredericCFO 2016-11-18Sell3,900$28.19-7.41view
Herman Alan C.Chief Scientific Officer 2016-11-01Sell11,333$27.53-5.19view
Viret Jean-FredericCFO 2016-10-21Sell3,900$30.62-14.76view
Herman Alan C.Chief Scientific Officer 2016-10-03Sell11,333$25.691.6view
Viret Jean-FredericCFO 2016-09-26Sell3,900$29.88-12.65view
Lanfear Dennis MPresident and CEO 2016-09-21Sell4,060$31.75-17.8view

Quarterly/Annual Reports about CHRS:

News about CHRS:

Articles On GuruFocus.com
Coherus Biosciences' Humira Petition Denied Nov 08 2016 
A Look at Pharma Company Dermira's Performance Mar 27 2015 

More From Other Websites
ETFs with exposure to Coherus BioSciences, Inc. : January 19, 2017 Jan 19 2017
Coherus Offers Positive Phase III Data on Humira Biosimilar Jan 13 2017
Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420... Jan 10 2017
Coherus BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : CHRS-US : January... Jan 10 2017
Coherus BioSciences Management to Present at The 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Coherus BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : CHRS-US :... Dec 19 2016
Coherus BioSciences to Present at BMO – Prescriptions for Success Healthcare Conference on... Dec 07 2016
Coherus BioSciences, Inc. – Value Analysis (NASDAQ:CHRS) : December 7, 2016 Dec 07 2016
Coherus BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : CHRS-US :... Dec 06 2016
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 30 2016
Coherus’ Marketing Authorization Application to European Medicines Agency for CHS-1701... Nov 29 2016
Is The Rubicon Project Inc (RUBI) A Good Stock To Buy? Nov 28 2016
Coherus BioSciences Announces New Employment Inducement Grants Nov 17 2016
Coherus BioSciences Announces New Employment Inducement Grants Nov 17 2016
COHERUS BIOSCIENCES, INC. Financials Nov 17 2016
Edited Transcript of CHRS earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
Coherus BioSciences Inc Earnings Call scheduled for 4:30 pm ET today Nov 09 2016
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 09 2016
Coherus BioSciences Reports Third Quarter 2016 Operating and Financial Results Nov 09 2016
Coherus BioSciences Reports Third Quarter 2016 Operating and Financial Results Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)